Endometriosis patients benefit from high serum progesterone in hormone replacement therapy-frozen embryo transfer cycles: a cohort study
article
OA: hybrid
CC0
⤵ 9 in-corpus citations
AI-generated summary
Endometriosis patients undergoing HRT-FET cycles had higher live birth rates with serum progesterone levels of 118 nmol/l or above compared to lower levels.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
RESEARCH QUESTION: What is the optimal serum progesterone cut-off level in patients with endometriosis undergoing hormone replacement therapy frozen embryo transfer (HRT-FET) with intensive progesterone luteal phase support?
DESIGN: A cohort study, including 262 HRT-FET cycles in 179 patients all diagnosed with endometriosis either by laparoscopy or by ultrasound in patients with visible endometriomas. Pre-treatment consisted of 42 days of oral contraceptive pills and 5 days' wash-out, followed by 6 mg oral oestrogen daily. Exogenous progesterone supplementation with vaginal progesterone gel 90 mg/12h commenced when the endometrium was 7 mm or thicker. From the fourth day of vaginal progesterone supplementation, patients also received intramuscular progesterone 50 mg daily. Blastocyst transfer was scheduled for the sixth day of progesterone supplementation.
RESULTS: The overall positive HCG, live birth (LBR) and total pregnancy loss rates were 60%, 39% and 34%, respectively. The optimal progesterone cut-off level was 118 nmol/l (37.1 ng/ml) defined as the maximum of the Youden index. The unadjusted LBR was significantly higher in patients with progesterone measuring 118 nmol/l or above compared with patients with progesterone measuring less than 118 nmol/l (51% [44/86] versus 34% [59/176], P = 0.01), whereas the adjusted odds ratio for a live birth was 2.1 (95% CI 1.2 to 3.7) after adjusting for age, body mass index, blastocyst score, blastocyst age, quality and number of blastocysts transferred.
CONCLUSIONS: Serum progesterone levels above 118 nmol/l (37.1ng/ml) resulted in significantly higher LBR compared with lower serum progesterone levels, suggesting that a threshold for optimal serum progesterone exists.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (48)
- Analysis of serum and endometrial progesterone in determining endometrial receptivity via openalex
- Assisted reproductive technology for women with endometriosis, a clinically oriented review via openalex
- Bowel Endometriosis Syndrome: a new scoring system for pelvic organ dysfunction and quality of life via openalex
- Endometrial receptivity in eutopic endometrium in patients with endometriosis: it is not affected, and let me show you why via openalex
- Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why via openalex
- Estrogen receptor β and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis via openalex
- Gene Expression Analysis of Endometrium Reveals Progesterone Resistance and Candidate Susceptibility Genes in Women with Endometriosis via openalex
- History of endometriosis may adversely affect the outcome in menopausal recipients of sibling oocytes via openalex
- Homeostasis Imbalance in the Endometrium of Women with Implantation Defects: The Role of Estrogen and Progesterone via openalex
- Influence of Endometriosis on Assisted Reproductive Technology Outcomes via openalex
- Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis? via openalex
- Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Endometriosis via openalex
- Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Role of Estrogen Receptor-β in Endometriosis via openalex
- Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes via openalex
- W2605651913 via openalex
- W2762859009 via openalex
- W2894695736 via openalex
- W2899241696 via openalex
- W2906107223 via openalex
- W2908029558 via openalex
- W3004273286 via openalex
- W3008547364 via openalex
- W3132048214 via openalex
- W3135906313 via openalex
- W3157352057 via openalex
- W3190345669 via openalex
- W3199492746 via openalex
- W3211041473 via openalex
- W4206248186 via openalex
- W6673771426 via openalex
- W4242030375 via openalex
- W6757264759 via openalex
- W6799400504 via openalex
- W6803716800 via openalex
- W6806865447 via openalex
- W84583857 via openalex
- W858408936 via openalex
- W1112795483 via openalex
- W1512555213 via openalex
- W2124988811 via openalex
- W2129213273 via openalex
- W2131022957 via openalex
- W2150780222 via openalex
- W2153114583 via openalex
- W2159203244 via openalex
- W2169827333 via openalex
Cited by (10)
- Serum progesterone concentrations at frozen embryo transfer in women with adenomyosis and endometriosis: a retrospective cohort study 2026
- GnRH Agonist-Aromatase Inhibitor Pretreatment Before Frozen Embryo Transfer in Patients with Endometriosis, Adenomyosis or Both 2026
- Clinical challenges and therapeutic strategies in women with endometriosis, deep infiltrating endometriosis, and/or adenomyosis undergoing assisted reproductive technologies: a narrative review 2026
- Cumulative live birth rates under three consecutive IVF/ICSI treatment cycles are reduced in women with endometriosis and/or adenomyosis diagnosed by ultrasonography 2025
- Predictive Role of Progesterone Levels for IVF Outcome in Different Phases of Controlled Ovarian Stimulation for Patients With and Without Endometriosis: Expert View 2024
- Role of Progestins in Reproduction 2024
- Reply: Sticking to the facts instead of speculating: evidence against intensive luteal phase support in endometriosis patients undergoing HRT-FET cycles 2024
- The devil lies in the detail-the role of intensive exogenous progesterone supplementation in the endometriosis patient undergoing HRT-FET 2024
- Progesterone levels do not differ between patients with or without endometriosis/adenomyosis both in those who conceive after hormone replacement therapy-frozen embryo transfer cycles and those who do not 2024
- Reply of the authors: Endometrial receptivity in adenomyosis and/or endometriosis 2023
Source provenance
- europepmc
- last seen: 2026-09-25T06:10:54.854274+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-09-15T06:16:54.591090+00:00
License: CC0
· commercial use OK